Laboratories Ojer Pharma SL:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Laboratories Ojer Pharma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10586
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Laboratories Ojer Pharma SL (Ojer Pharma) is a developer of pharmaceutical products in dermatology. The company’s products categories include prescription medicine, over the counter OTC, medical devices and cosmetic products. It offers products such as previderm, dermatul nasal, dermatul lipogel, lipovir gel and dermatul queratosis, among others. Ojer Pharma’s products find application for the treatment of diseases such as dermatitis, ulcerations, infections and wound care protection, among others. The company conducts research and development activities for the treatment of dermatological diseases. It works in partnership with other universities and research institutes. Ojer Pharma is headquartered in Pamplona, Spain.

Laboratories Ojer Pharma SL – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Laboratories Ojer Pharma Raises USD0.8 Million in Venture Financing 10
Partnerships 11
Laboratories Ojer Pharma, College of Pharmacy of the University of Barcelona and Tecnalia Enter into Co-Development Agreement 11
Reig Jofre Enters Into Co-Development Agreement With Ojer Pharma For Nobactine 12
Laboratories Ojer Pharma SL – Key Competitors 13
Laboratories Ojer Pharma SL – Key Employees 14
Laboratories Ojer Pharma SL – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Key Facts 2
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laboratories Ojer Pharma SL, Deals By Therapy Area, 2012 to YTD 2018 8
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Laboratories Ojer Pharma Raises USD0.8 Million in Venture Financing 10
Laboratories Ojer Pharma, College of Pharmacy of the University of Barcelona and Tecnalia Enter into Co-Development Agreement 11
Reig Jofre Enters Into Co-Development Agreement With Ojer Pharma For Nobactine 12
Laboratories Ojer Pharma SL, Key Competitors 13
Laboratories Ojer Pharma SL, Key Employees 14

List of Figures
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Laboratories Ojer Pharma SL:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nevro Corp (NVRO):企業の財務・戦略的SWOT分析
    Summary Nevro Corp (Nevro) is a medical device company which focuses on providing novel products that advance the quality of life of people suffering from chronic pain. The company has developed Nevro Senza spinal cord stimulation (SCS) system, a non-pharmacologic neuromodulation platform for the tr …
  • Conatus Pharmaceuticals Inc (CNAT):企業の財務・戦略的SWOT分析
    Summary Conatus Pharmaceuticals Inc (Conatus) is a biotechnology company that develops and commercializes novel medicines for the treatment of liver diseases. The company’s lead pipeline candidate includes emricasan, an orally active pan-caspase protease inhibitor which is designed to reduce the act …
  • Lipocine Inc (LPCN):企業の財務・戦略的SWOT分析
    Summary Lipocine Inc (Lipocine) is a pharmaceutical company that develops and commercializes treatment for men's and women's health. The company’s pipeline products for men’s health include LPCN 1111 and LPCN 1021; and for women’s health include LPCN 1107. Its LPCN 1111 is an oral testosterone produ …
  • TransGenic Inc (2342):企業の財務・戦略的SWOT分析
    TransGenic Inc (2342) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Cedar Fair, L.P.:企業の戦略・SWOT・財務情報
    Cedar Fair, L.P. - Strategy, SWOT and Corporate Finance Report Summary Cedar Fair, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Trevena Inc (TRVN):製薬・医療:M&Aディール及び事業提携情報
    Summary Trevena Inc (Trevena) is a biotechnology company that discovers and develops G-protein coupled receptor targeted medicines. The company provides products such as RV027, TRV130, TRV734 and TRV250. Its TRV027 is an intravenous drug used for the treatment of acute heart failure in combination w …
  • SQI Diagnostics Inc (SQD):企業の財務・戦略的SWOT分析
    Summary SQI Diagnostics Inc (SQI Diagnostics) is a diagnostic company that provides in vitro diagnostic and pharmaceutical research products. It provides products such as sqidworks, sqidlite and sqid-X. Its sqidworks system is used in labs. SQI Diagnostic’s sqidlite is a practical benchtop system. I …
  • Arthur J. Gallagher & Co:企業のM&A・事業提携・投資動向
    Arthur J. Gallagher & Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Arthur J. Gallagher & Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Husky Energy Inc (HSE):石油・ガス:M&Aディール及び事業提携情報
    Summary Husky Energy Inc (Husky) is an integrated energy company. It operates across the oil and gas value chain. Its upstream operations include the exploration, development and production of crude oil, bitumen, natural gas and natural gas liquids (NGL). Its midstream operations include pipeline tr …
  • Stockmann plc (STCBV):企業の財務・戦略的SWOT分析
    Stockmann plc (STCBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • The Bank of Iwate Ltd:企業の戦略・SWOT・財務情報
    The Bank of Iwate Ltd - Strategy, SWOT and Corporate Finance Report Summary The Bank of Iwate Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Alfa Group Consortium:企業の戦略的SWOT分析
    Alfa Group Consortium - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • B2W – Companhia Global Do Varejo
    B2W - Companhia Global Do Varejo - Strategy, SWOT and Corporate Finance Report Summary B2W - Companhia Global Do Varejo - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Energy Transfer LP:企業の戦略・SWOT・財務情報
    Energy Transfer LP - Strategy, SWOT and Corporate Finance Report Summary Energy Transfer LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Coca-Cola FEMSA SAB de CV:戦略・SWOT・企業財務分析
    Coca-Cola FEMSA SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola FEMSA SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • China Petroleum & Chemical Corporation (Sinopec):戦略・SWOT・企業財務分析
    China Petroleum & Chemical Corporation (Sinopec) - Strategy, SWOT and Corporate Finance Report Summary China Petroleum & Chemical Corporation (Sinopec) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Sumitomo Precision Products Co Ltd:企業の戦略・SWOT・財務分析
    Sumitomo Precision Products Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Precision Products Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Miltenyi Biotec GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Miltenyi Biotec GmbH (Miltenyi) is a biotechnology company that offers biomedical research and cellular therapy products for cell isolation, flow cytometry, sample preparation and cell culture. The company offers sample preparation, cell separation, flow cytometry, cell culture and stimulati …
  • United Natural Foods Inc:戦略・SWOT・企業財務分析
    United Natural Foods Inc - Strategy, SWOT and Corporate Finance Report Summary United Natural Foods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Insys Therapeutics Inc (INSY):企業の財務・戦略的SWOT分析
    Insys Therapeutics Inc (INSY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆